−0.13EUR
−6.46 MEUR
38.38 MEUR
21.03 M
About CLNPHARMA
Sector
CEO
Maciej Wieczorek
Headquarters
Lomianki
Website
Employees (FY)
515
Founded
2002
ISIN
PLCLNPH00015
FIGI
BBG00ZHRD7N9
Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm's products include Aromek, Donepex, Ketrel, Salmex, and Valzek. It operates through the Generic Drug and Innovative segments. The Generic Drug segment pertains to the manufacture and sale of drugs registered and authorized for marketing. The Innovative segment involves activities that develop the documentation on the basis of which a drug could be registered or commercialized at the stage prior to drug registration. The company was founded by Maciej Wieczorek on June 20, 2002 and is headquartered in Lomianki, Poland.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 8RP is 3.69 EUR — it hasn't changed in the past 24 hours. Watch CELON PHARMA S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CELON PHARMA S.A. stocks are traded under the ticker 8RP.
8RP stock hasn't changed in a week, the month change is a 2.38% fall, over the last year CELON PHARMA S.A. has showed a 1.21% decrease.
We've gathered analysts' opinions on CELON PHARMA S.A. future price: according to them, 8RP price has a max estimate of 5.32 EUR and a min estimate of 2.78 EUR. Watch 8RP chart and read a more detailed CELON PHARMA S.A. stock forecast: see what analysts think of CELON PHARMA S.A. and suggest that you do with its stocks.
8RP stock is 0% volatile and has beta coefficient of 0.48. Track CELON PHARMA S.A. stock price on the chart and check out the list of the most volatile stocks — is CELON PHARMA S.A. there?
Today CELON PHARMA S.A. has the market capitalization of 184.91 M, it has decreased by 2.01% over the last week.
Yes, you can track CELON PHARMA S.A. financials in yearly and quarterly reports right on TradingView.
8RP net income for the last quarter is −3.65 M EUR, while the quarter before that showed −3.44 M EUR of net income which accounts for −5.99% change. Track more CELON PHARMA S.A. financial stats to get the full picture.
Yes, 8RP dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 0.51%. Tracking CELON PHARMA S.A. dividends might help you take more informed decisions.
As of Jun 29, 2024, the company has 515.00 employees. See our rating of the largest employees — is CELON PHARMA S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELON PHARMA S.A. EBITDA is −5.75 M EUR, and current EBITDA margin is −16.05%. See more stats in CELON PHARMA S.A. financial statements.
Like other stocks, 8RP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELON PHARMA S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELON PHARMA S.A. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELON PHARMA S.A. stock shows the buy signal. See more of CELON PHARMA S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.